Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Doxycycline hyclate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for doxycycline hyclate and what is the scope of doxycycline hyclate freedom to operate?

Doxycycline hyclate
is the generic ingredient in fourteen branded drugs marketed by Chartwell Life Sci, Hikma Intl Pharms, Impax Labs Inc, Mylan Labs Ltd, Pfizer, Watson Labs, Mutual Pharm, Halsey, Actavis Labs Fl Inc, Pvt Form, Mylan, Aqua Pharms Llc, Par Pharm, Actavis Elizabeth, Sun Pharm Inds, Vintage Pharms, Collagenex, West-ward Pharms Int, Tolmar, Mylan Pharms Inc, Warner Chilcott, Aqua Pharms, Rachelle, Heritage Pharms Inc, Heather, Interpharm, Ivax Sub Teva Pharms, Superpharm, Caribe Holdings, Fresenius Kabi Usa, Lannett, Ranbaxy, Medicis, Teva, Mayne Pharma Intl, Corepharma, Galderma Labs Lp, Pliva, Larken Labs, Amneal Pharms, Prinston Inc, and Mayne Pharma, and is included in sixty-five NDAs. There are six patents protecting this compound and six Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Doxycycline hyclate has two patent family members in two countries.

There are twenty-seven drug master file entries for doxycycline hyclate. Ninety-two suppliers are listed for this compound.

Summary for Generic Name: doxycycline hyclate

Tradenames:14
Patents:6
Applicants:42
NDAs:65
Drug Master File Entries: see list27
Suppliers / Packagers: see list92
Bulk Api Vendors: see list63
Clinical Trials: see list73
Patent Applications: see list2,079
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:doxycycline hyclate at DailyMed

Pharmacology for Ingredient: doxycycline hyclate

Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mutual Pharm
DOXYCYCLINE HYCLATE
doxycycline hyclate
CAPSULE;ORAL062418-002Jan 28, 1983DISCNNoNo► Subscribe► Subscribe
Impax Labs Inc
DOXYCYCLINE HYCLATE
doxycycline hyclate
TABLET, DELAYED RELEASE;ORAL090505-002Dec 28, 2010DISCNNoNo► Subscribe► Subscribe
Pliva
DOXYCYCLINE HYCLATE
doxycycline hyclate
CAPSULE, COATED PELLETS;ORAL063187-001Jun 30, 1992DISCNNoNo► Subscribe► Subscribe
Pfizer
VIBRA-TABS
doxycycline hyclate
TABLET;ORAL050533-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Mayne Pharma
DORYX
doxycycline hyclate
TABLET, DELAYED RELEASE;ORAL050795-006Dec 19, 2014ABRXYesNo6,958,161► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot